These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 11823628)

  • 1. Neurobiology. Chaperones take flight.
    Helfand SL
    Science; 2002 Feb; 295(5556):809-10. PubMed ID: 11823628
    [No Abstract]   [Full Text] [Related]  

  • 2. Chaperone suppression of alpha-synuclein toxicity in a Drosophila model for Parkinson's disease.
    Auluck PK; Chan HY; Trojanowski JQ; Lee VM; Bonini NM
    Science; 2002 Feb; 295(5556):865-8. PubMed ID: 11823645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurobiology. Of flies and mice.
    Dawson VL
    Science; 2000 Apr; 288(5466):631-2. PubMed ID: 10799001
    [No Abstract]   [Full Text] [Related]  

  • 4. Biomedicine. Combating Parkinson's disease--step three.
    Olson L
    Science; 2000 Oct; 290(5492):721-4. PubMed ID: 11184202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Drosophila model of Parkinson's disease.
    Feany MB; Bender WW
    Nature; 2000 Mar; 404(6776):394-8. PubMed ID: 10746727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Could a loss of alpha-synuclein function put dopaminergic neurons at risk?
    Perez RG; Hastings TG
    J Neurochem; 2004 Jun; 89(6):1318-24. PubMed ID: 15189334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New movement in Parkinson's.
    Lozano AM; Kalia SK
    Sci Am; 2005 Jul; 293(1):68-75. PubMed ID: 16008304
    [No Abstract]   [Full Text] [Related]  

  • 8. Applying chaperones to protein-misfolding disorders: molecular chaperones against α-synuclein in Parkinson's disease.
    Chaari A; Hoarau-Véchot J; Ladjimi M
    Int J Biol Macromol; 2013 Sep; 60():196-205. PubMed ID: 23748003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A single amino acid substitution differentiates Hsp70-dependent effects on alpha-synuclein degradation and toxicity.
    Klucken J; Shin Y; Hyman BT; McLean PJ
    Biochem Biophys Res Commun; 2004 Dec; 325(1):367-73. PubMed ID: 15522241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha-synuclein and neurodegenerative diseases.
    Goedert M
    Nat Rev Neurosci; 2001 Jul; 2(7):492-501. PubMed ID: 11433374
    [No Abstract]   [Full Text] [Related]  

  • 11. Hsp70 molecular chaperones and Parkinson's disease.
    Witt SN
    Biopolymers; 2010 Mar; 93(3):218-28. PubMed ID: 19768775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. alpha -Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease.
    Lo Bianco C; Ridet JL; Schneider BL; Deglon N; Aebischer P
    Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10813-8. PubMed ID: 12122208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lewy bodies in Parkinson's disease: protectors or perpetrators?
    Harrower TP; Michell AW; Barker RA
    Exp Neurol; 2005 Sep; 195(1):1-6. PubMed ID: 16023637
    [No Abstract]   [Full Text] [Related]  

  • 14. Parkinson's disease. Dopamine may sustain toxic protein.
    Couzin J
    Science; 2001 Nov; 294(5545):1257-8. PubMed ID: 11701896
    [No Abstract]   [Full Text] [Related]  

  • 15. Mechanisms of chaperone suppression of polyglutamine disease: selectivity, synergy and modulation of protein solubility in Drosophila.
    Chan HY; Warrick JM; Gray-Board GL; Paulson HL; Bonini NM
    Hum Mol Genet; 2000 Nov; 9(19):2811-20. PubMed ID: 11092757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. alpha-synuclein and cytosolic dopamine: stabilizing a bad situation.
    Sulzer D
    Nat Med; 2001 Dec; 7(12):1280-2. PubMed ID: 11726961
    [No Abstract]   [Full Text] [Related]  

  • 17. Neuroscience. Parkin and its substrates.
    Haass C; Kahle PJ
    Science; 2001 Jul; 293(5528):224-5. PubMed ID: 11452103
    [No Abstract]   [Full Text] [Related]  

  • 18. Hsp70 gene transfer by adeno-associated virus inhibits MPTP-induced nigrostriatal degeneration in the mouse model of Parkinson disease.
    Dong Z; Wolfer DP; Lipp HP; Büeler H
    Mol Ther; 2005 Jan; 11(1):80-8. PubMed ID: 15585408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A stable proportion of Lewy body bearing neurons in the substantia nigra suggests a model in which the Lewy body causes neuronal death.
    Greffard S; Verny M; Bonnet AM; Seilhean D; Hauw JJ; Duyckaerts C
    Neurobiol Aging; 2010 Jan; 31(1):99-103. PubMed ID: 18457903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Dopaminergic neuronal death in Parkinson's disease: is accumulation of unfolded proteins a cause or effect?].
    Imai Y; Takahashi R
    Tanpakushitsu Kakusan Koso; 2004 May; 49(7 Suppl):1113-7. PubMed ID: 15168542
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.